ASH 2015 | From epigenetic mechanisms to cancer therapeutics

Name: From epigenetic mechanisms to cancer therapeutics
Uploaded: 2015-12-04T00:00:00.000Z
Duration: 3 min 19 s
Description: At the 58th American Society of Hematology (ASH) Annual Meeting & Exposition, Stephen Nimer, MD, from Memorial Sloan-Kettering Cancer Center, New York, NY, reviews promising epigenetic targets in cancer and explains that combining epigenetic therapies with immunotherapies may improve outcomes for patients.

Stephen Nimer • 4 Dec 2015

ASH 2015

General

At the 58th American Society of Hematology (ASH) Annual Meeting & Exposition, Stephen Nimer, MD, from Memorial Sloan-Kettering Cancer Center, New York, NY, reviews promising epigenetic targets in cancer and explains that combining epigenetic therapies with immunotherapies may improve outcomes for patients.